World Preview 2024 – Pharma’s Growth Boost – Infographic

After an Age of Uncertainty, the pharmaceutical industry is now shifting into a period with more predictable trends, where big pharma continues to focus on big drugs for big diseases. Evaluate’s latest forecasts are here, giving you the view to 2030. Will obesity still lead the way? Will new modalities and technologies open up fresh […]

Share:

Download today








After an Age of Uncertainty, the pharmaceutical industry is now shifting into a period with more predictable trends, where big pharma continues to focus on big drugs for big diseases.

Evaluate’s latest forecasts are here, giving you the view to 2030. Will obesity still lead the way? Will new modalities and technologies open up fresh possibilities? And with ongoing patent expirations, who will be most affected this decade?

Download the World Preview 2024 Infographic to see what’s on the horizon.

Get insights on:

  • The view to 2030: How big will the market grow?
  • Growth engines: Top-selling products worldwide
  • Industry heavyweights: Top companies by 2030
  • Innovation spend: Global R&D investment
  • Watchlist: Key developments to monitor

Upcoming Webinar

China Pipelines, Western Portfolios

Tuesday 14th July 3pm BST | 10am ET

Western pharma committed close to $2 billion in licensing deals and acquisitions for China-originated assets in Q1 2026 alone.

Related Content